Sparfosate -: A novel biomodulator of 5-fluorouracil

被引：0

作者：

Koshland, P ^{[1
]}

Maa, L ^{[1
]}

Ignoffo, R ^{[1
]}

机构：

[1] Univ Calif San Francisco, Sch Pharm, Stanford Hlth Care, San Francisco, CA 94143 USA

来源：

CANCER PRACTICE | 1999年 / 7卷 / 04期

关键词：

D O I：

10.1046/j.1523-5394.1999.74011.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：212 / 216

页数：5

共 26 条

[1]

*ACS, 1999 FACTS FIG SPEC

[2]

*ACS, AG ADJ CANC DEATH RA

[3] PHOSPHORIBOSYL PYROPHOSPHATE, POOL SIZE AND TISSUE-LEVELS AS A DETERMINANT OF 5-FLUOROURACIL RESPONSE IN MURINE COLONIC ADENOCARCINOMAS [J].

ARDALAN, B ;

VILLACORTE, D ;

HECK, D ;

CORBETT, T .

BIOCHEMICAL PHARMACOLOGY, 1982, 31 (11) :1989-1992

[4] A RANDOMIZED PHASE-I AND PHASE-II STUDY OF SHORT-TERM INFUSION OF HIGH-DOSE FLUOROURACIL WITH OR WITHOUT N-(PHOSPHONACETYL)-L-ASPARTIC ACID IN PATIENTS WITH ADVANCED PANCREATIC AND COLORECTAL CANCERS [J].

ARDALAN, B ;

SINGH, G ;

SILBERMAN, H .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) :1053-1058

[5]

BEDIKIAN AY, 1980, P AM ASSOC CANC RES, V21, P415

[6]

BEDIKIAN AY, 1981, CANCER TREAT REP, V65, P747

[7]

DeVita VT., 1997, CANC PRINCIPLES PRAC, V5th

[8]

ERLICHMAN C, 1980, CANCER RES, V40, P1902

[9]

ERLICHMAN C, 1979, CANCER RES, V39, P3992

[10]

ERLICHMAN C, 1982, J NATL CANCER I, V68, P331

← 1 2 3 →